Vesalius Longevity Labs Appoints Longevity Entrepreneur Dr. Peter Diamandis to Its Board of Directors
Vancouver, British Columbia – (November 19, 2026) – Vesalius Longevity Labs Inc. announced the addition of Dr. Peter Diamandis to its Board of Directors. Dr. Diamandis, a renowned entrepreneur and thought leader in longevity, exponential technology, and health innovation, joins the board effective immediately. With a career spanning 25 companies across various sectors, Dr. Diamandis is the Founder and Executive Chairman of the XPRIZE Foundation and the Executive Founder of Singularity University.
He holds an M.D. from Harvard Medical School and has authored several New York Times bestsellers. As a member of Vesalius' Board, Dr. Diamandis will contribute to the company's strategy, focusing on its peptide and longevity platform, scientific positioning, and strategic partnerships. His expertise is expected to help scale Vesalius' mission of making longevity medicine more accessible and trusted.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.